Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06182189
Other study ID # 2014 - IPB
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date December 1, 2014
Est. completion date December 31, 2034

Study information

Verified date December 2023
Source IRCCS San Raffaele
Contact Andrea Salonia, MD
Phone 02 2643 5661
Email salonia.andrea@hsr.it
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Prospective observational study on the quality of life of patients with BPH under medical therapy and/or undergoing surgery.


Description:

Prospective observational study on the quality of life of patients with BPH under medical therapy and/or undergoing surgery. Data relating to the clinical conditions (state of the disease, psychological and related to the quality of life) of patients suffering from BPH under medical therapy and/or undergoing surgery will be collected within a specially designed database which will allow us to easily and secure extraction of data used for statistical analyzes in clinical research.


Recruitment information / eligibility

Status Recruiting
Enrollment 8000
Est. completion date December 31, 2034
Est. primary completion date December 31, 2024
Accepts healthy volunteers No
Gender Male
Age group 18 Years and older
Eligibility Inclusion Criteria: - subjects suffering from benign prostatic hyperplasia undergoing medical therapy and/or undergoing surgery - subjects >= 18 years old - signature of informed consent Exclusion Criteria: - subjects < 18 years - presence of mental or physical disability that may prevent the patient from answering the questionnaires.

Study Design


Intervention

Other:
Observation of patients with a benign prostatic hyperplasia condition
Observation of patients with a benign prostatic hyperplasia condition who have undergone surgery

Locations

Country Name City State
Italy IRCCS Ospedale San Raffaele Milan Lombardy

Sponsors (1)

Lead Sponsor Collaborator
IRCCS San Raffaele

Country where clinical trial is conducted

Italy, 

Outcome

Type Measure Description Time frame Safety issue
Primary Medical history - patient's medical history, past surgical history, family medical history, social history, allergies, medications; Baseline
Primary Psycho-behavioural data - male sexual health Male sexual health assessed through the Questionnaire for the evaluation of male sexual health" MSHQ(25-item, range: 7 - 80, greater score indicating better function, Baseline and up to 6 months
Primary Physical examination - Body temperature Body temperature detection (Celsius degree) Baseline
Primary Psycho-behavioural data - erectile function Erectile function assessed through the "International Index of Erectile Function" questionnaire IIEF (scoring: 1 - 30 - 6-10: severe; 11-16: Moderate; 17-25: mild; 26-30: absence Baseline and up to 6 months
Primary Prostatic Symptoms Prostatic Symptoms assessed through the IPSS questionnaire, International Prostatic Symptoms Score: , Scoring 0 -7, 0-7 mild symptoms, 8-19 moderate symptoms, 20-35 severe symptoms; Baseline and up to 6 months
Primary Incontinence Symptoms Incontinence Symptoms assessed through the ICIQ - International Consultation of Incontinence Questionnaire, ICIQ-SF has a maximum score of 21; the higher the score, the more severe is the UI, but there is no normal score; Baseline and up to 6 months
Primary Physical examination - Body temperature pulse rate Pulse rate detection (beats per minute) Baseline
Primary Physical examination - respiration assessment Respiration rate detection (breaths per minute) Baseline
Primary Physical examination - blood pressure Blood pressure detection (mmHg) Baseline
See also
  Status Clinical Trial Phase
Recruiting NCT04807296 - Thulium Fiber Laser Enucleation of the Prostate (TFLEP) vs HoLEP With Moses Technology (m-HoLEP) N/A
Recruiting NCT05574244 - Comparison of Functional Outcomes of Ejaculation-preserving Partial Trans Urethral Resection of the Prostate With Complete Trans Urethral Resection of the Prostate for Benign Prostatic Obstruction N/A
Recruiting NCT04288427 - 5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy N/A
Not yet recruiting NCT04245566 - Prostatic Artery Embolization vs. Pharmacotherapy for LUTS/BPH Phase 3
Withdrawn NCT01967251 - Efficacy, Safety and Dose-response of Udenafil in Patients With Benign Prostatic Hyperplasia and Erectile Dysfunction Phase 2
Completed NCT03246880 - Clinical Trial To Evaluate the Efficacy and Safety of CKD-397 in Benign Prostatic Hyperplasia Patients Phase 3
Completed NCT02509975 - Safety and Efficacy of OCL 503 in Prostate Artery Embolization N/A
Completed NCT02283684 - GreenLight Laser Photoselective Vaporization of the Prostate vs Bipolar Transurethral Vaporization of the Prostate; RCT Phase 4
Completed NCT02206243 - Embozene® Microspheres for Prostatic Arterial Embolization in Patients With Symptomatic Benign Prostatic Hyperplasia
Completed NCT01454349 - Study of PRX302 for Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia (BPH) Phase 1/Phase 2
Completed NCT01438775 - Phase 3 Evaluation of Re-Injection of NX-1207 for the Treatment of Benign Prostatic Hyperplasia (BPH) Phase 3
Completed NCT01139762 - A Study of Tadalafil Use With Finasteride in Men With Enlarged Prostates and Urinary Symptoms Phase 3
Completed NCT01152190 - A Study in Benign Prostatic Hyperplasia Phase 3
Active, not recruiting NCT00400894 - Annexin A3 (ANXA3) as Protein-Based Marker for Non-Invasive Molecular Diagnostics of Prostate Carcinoma N/A
Unknown status NCT00381108 - Study of the Effects of Pomegranate Tablets on Enlarged Prostates Phase 1
Completed NCT00701779 - Dutasteride and Flex Dose of Tamsulosin on as Needed Basis, to Treat Benign Prostatic Hyperplasia Phase 4
Completed NCT00224133 - The Evaluation of the Safety of a New Drug for Benign Prostatic Hyperplasia Used for 9 Months Phase 3
Terminated NCT02962674 - To Evaluate the Safety and Performance of the ProstaCare Water Electrolysis System in Relieving Symptoms of BPH. N/A
Active, not recruiting NCT05415748 - Deprescribing Tamsulosin in Older Men Phase 4
Recruiting NCT04853914 - Evaluation of the Safety of the Treatment of Benign Prostatic Hyperplasia by High Intensity Focused Ultrasound. N/A